193 related articles for article (PubMed ID: 32839916)
41. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
Sung H; Freedman RA; Siegel RL; Hyun N; DeSantis CE; Ruddy KJ; Jemal A
Cancer; 2021 Sep; 127(18):3310-3324. PubMed ID: 34002851
[TBL] [Abstract][Full Text] [Related]
42. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
43. Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors.
Ye X; Tan Y; Ma R; Lou P; Yuan Y
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629753
[No Abstract] [Full Text] [Related]
44. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
45. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Kry SF; Gilbert E; Lamart S; Berg CD; Stovall M; Ron E
Lancet Oncol; 2011 Apr; 12(4):353-60. PubMed ID: 21454129
[TBL] [Abstract][Full Text] [Related]
46. Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016.
Mukand NH; Zolekar A; Ko NY; Calip GS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2220-2229. PubMed ID: 32856609
[TBL] [Abstract][Full Text] [Related]
47. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
48. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
49. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
[TBL] [Abstract][Full Text] [Related]
50. Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000-2015: Population-based analysis.
Odani S; Tabuchi T; Nakata K; Morishima T; Kuwabara Y; Koyama S; Kudo H; Kato M; Miyashiro I
Cancer Med; 2022 Jan; 11(2):507-519. PubMed ID: 34845852
[TBL] [Abstract][Full Text] [Related]
51. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
52. Risk of prostate cancer among cancer survivors in the Netherlands.
Kok DE; van de Schans SA; Liu L; Kampman E; Coebergh JW; Kiemeney LA; Soerjomataram I; Aben KK
Cancer Epidemiol; 2013 Apr; 37(2):140-5. PubMed ID: 23265853
[TBL] [Abstract][Full Text] [Related]
53. Concordance of cancer registry and self-reported race, ethnicity, and cancer type: a report from the American Cancer Society's studies of cancer survivors.
Layne TM; Ferrucci LM; Jones BA; Smith T; Gonsalves L; Cartmel B
Cancer Causes Control; 2019 Jan; 30(1):21-29. PubMed ID: 30392148
[TBL] [Abstract][Full Text] [Related]
54. Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity - United States, 2001-2017.
Siegel DA; O'Neil ME; Richards TB; Dowling NF; Weir HK
MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(41):1473-1480. PubMed ID: 33056955
[TBL] [Abstract][Full Text] [Related]
55. Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology.
Othmane B; Yi Z; Zhang C; Chen J; Zu X; Fan B
Front Public Health; 2022; 10():1036722. PubMed ID: 36466542
[TBL] [Abstract][Full Text] [Related]
56. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
Kim C; Bi X; Pan D; Chen Y; Carling T; Ma S; Udelsman R; Zhang Y
Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
[TBL] [Abstract][Full Text] [Related]
57. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
58. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
59. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
60. Association of race/ethnicity and patient care experiences with healthcare utilization and healthcare costs among prostate cancer survivors: A SEER-CAHPS study.
Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
J Geriatr Oncol; 2024 Apr; 15(3):101748. PubMed ID: 38493533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
